Search Results - M. Subklewe

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT by L. Frölich, V. Blumenberg, K. Rejeski, C. Schmidt, M. Winkelmann, F. Schöberl, L. von Baumgarten, W. Kunz, V. Bücklein, M. Subklewe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P04.03 Immuno-analytics of patients with gastric cancer: impact of systemic polychemotherapy on peripheral T-cell fitness and immunologic features of gastric cancer tissue by D Zhang, M Subklewe, L Weiss, K Dorman, A Reischer, L Rohrbacher, S Boeck, T Haase, A Grosser, C Gießen-Jung, V Heinemann

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  3. 3

    P12.12 The tumor microenvironment of epithelial ovarian cancer: exhausted and immunosuppressive by F Trillsch, A Burges, M Subklewe, M von Bergwelt-Baildon, G Hänel, A Reischer, B Czogalla, A Leutbecher, S Geweniger, A-S Neumann

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  4. 4

    P1445: MYTCELL®: AN INTERACTIVE SMARTPHONE APPLICATION FOR CARS AND BITES INCREASES GUIDELINE ACCESSIBILITY AND REDUCES TIME TO APPLY EVIDENCE-BASED PATIENT CARE by V. Blumenberg, L. Siegmund, L. Frölich, K. Rejeski, M. Warm, F. Hildebrand, C. Schmidt, M. von Bergwelt, V. Bücklein, M. Subklewe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  5. 5

    P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE C... by K. Rejeski, V. Blumenberg, F. Hildebrand, L. Frölich, P. Karschnia, M. Dreyling, M. von Bergwelt-Baildon, C. Schmidt, M. Subklewe, V. Bücklein

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  6. 6

    P1402: ALTERATIONS OF HUMAN BONE MARROW NICHE IN CLONAL HEMATOPOIESIS AND AML by Y. Dragieva, M. Rothenberg-Thurley, B. Ksienzyk, A. Hadzic, A. Paulus, B. Tast, M. Subklewe, K. Spiekermann, S. Theurich, K. Metzeler, M. Solovey, F. Ziemann

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  7. 7

    P12.02 Adaptor P329G-directed CAR T cells for modular targeting of AML by C Klein, S Stock, S Endres, S Kobold, M Subklewe, M von Bergwelt-Baildon, A Gottschlich, L Rohrbacher, D Darowski, T Strzalkowski, L Fertig, VD Menkhoff, M Surowka, P Bruenker

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  8. 8

    P433: ADAPTER HOLIDAYS MAINTAIN IN-VITRO ADCAR-T CELL FUNCTIONALITY AGAINST AML by D. Nixdorf, M. Sponheimer, D. Berghammer, N. Zieger, L. Rohrbacher, S. Dapa, C. M. Seitz, K. Brandstetter, M. von Bergwelt-Baildon, H. Leonhardt, J. Mittelstaet, A. Kaiser, V. Bücklein, M. Subklewe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  9. 9

    10.02 Combined anti-angiogenic treatment to increase intratumoral persistence of CAR T-cells in lung cancer brain metastases by M Subklewe, T Xu, N Thon, S Langer, L von Baumgarten, C Eberle, VR Buchholz, J Blobner, L Dengler, JJ Herold, A Mühlbauer, KJ Müller, N Teske, P Karschnia, H Ishikawa-Ankerhold, J Tonn

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  10. 10

    P09.01 Adapting immune cells to the hypoglycemic tumor microenvironment by solute carrier 2a1 (Slc2a1/GLUT1) overexpression by A Hadzic, S Kobold, M Subklewe, S Theurich, M von Bergwelt-Baildon, S Michaelides, BL Cadilha, MR Benmebarek, W Schmitz, M Vaeth, D Briukhovetska, B Tast, ME Kirmaier, V Buschinger, CH Bönigk, S Oganesian, L Vona, A Tischmacher, V Heissmeyer, VR Buchholz, M Eilers

    Published in Journal for ImmunoTherapy of Cancer (2024-03-01)
    Article


  11. 11

    P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL by K. Rejeski, O. Albanyan, G. Iacoboni, V. Bücklein, V. Blumenberg, O. Penack, W. Bethge, S. Völkl, A. Perez, C. Carpio, C. Schmidt, N. Müller, K. Reid, R. Faramand, M. Davila, L. Bullinger, F. Locke, M. von Bergwelt-Baildon, A. Mackensen, P. Barba, M. Jain, M. Subklewe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  12. 12

    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CH... by V. Bücklein, A. Perez, G. Iacoboni, K. Rejeski, U. Holtick, O. Penack, S. Kharboutli, V. Blumenberg, J. Ackermann, L. Frölich, G. Johnson, K. Patel, B. Arciola, C. Schmidt, O. Albanyan, P. Gödel, E. Hoster, L. Bullinger, A. Mackensen, F. Locke, M. von Bergwelt, P. Barba, M. D. Jain, M. Subklewe

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  13. 13

    P356: SUBGROUP ANALYSES OF KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY, IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (... by B. D. Shah, R. D. Cassaday, J. H. Park, R. Houot, O. O. Oluwole, A. C. Logan, N. Boissel, T. Leguay, M. R. Bishop, M. S. Topp, D. Tzachanis, K. M. O’Dwyer, M. L. Arellano, Y. Lin, M. R. Baer, G. J. Schiller, M. Subklewe, M. Abedi, M. C. Minnema, W. G. Wierda, D. J. DeAngelo, P. Stiff, D. Jeyakumar, J. Dong, S. Adhikary, L. Zhou, P. C. Schuberth, B. Kharabi Masouleh, A. Ghobadi

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: